Atomoxetine (brand name Strattera) is a norepinephrine reuptake inhibitor approved for the treatment of attention deficit hyperactivity disorder (ADHD).This compound is manufactured, marketed, and sold in the United States as the hydrochloride salt (atomoxetine HCl) under the brand name Strattera. More information please visit the website: http://www.creative-peptides.com/product/atomoxetine-hydrochloride-item-10-101-111-13.html